Tugas 5 - Inventory
of 11
-
Upload
muhammad-rochim -
Category
Documents
-
view
214 -
download
0
Transcript of Tugas 5 - Inventory
-
8/12/2019 Tugas 5 - Inventory
1/11
Cost Method-INV PT PUAN & Subsidiary
Consolidated Financial Statement
per December 31, 2010
debit credit
Income Statement
Sales 1,000,000 650,000 400,000 1,250,000
Dividend Income 51,000 51,000 -
COGS (600,000) (390,000) 10,000 400,000 (600,000)
Deprecation expense (37,000) (30,000) 1,000 (66,000)
Operating expense (170,000) (85,000) (255,000)
Other operating expense (53,000) (25,000) 5,000 (83,000)
Net Income 191,000 120,000 246,000
NCI Expense 17,400 (17,400)
Consolidated Net Income 191,000 120,000 228,600
Beginning R/E 330,000 150,000 150,000 330,000
Dividend (100,000) (60,000) 60,000 (100,000)
Ending R/E 421,000 210,000 458,600
Balance Sheet
Cash 65,000 50,000 115,000
Account Receivable 55,000 45,000 40,000 60,000
Dividend Receivable 51,000 51,000 -
Inventory 80,000 50,000 10,000 120,000
Supplies 14,750 5,000 19,750
Land 300,000 230,000 35,000 565,000
Building 200,000 100,000 1,000 10,000 291,000
Equipment 200,000 150,000 350,000
Investment in SANTI 340,000 340,000 -
Patent 25,000 5,000 20,000
Total Assets 1,305,750 630,000 1,540,750
Account Payable 140,750 40,000 40,000 140,750
Dividend Payable 60,000 51,000 9,000
Other Liabilities 144,000 120,000 264,000
Capital Stock 600,000 200,000 200,000 600,000
Retained Earnings 421,000 210,000 458,600
NCI Equity 60,000 68,400
8,400
Total Liabilities + OE 1,305,750 630,000 985,400 985,400 1,540,750
Consolidated
Financial StatementAccounts PT PUAN PT SANTI
adjustment & elimination
-
8/12/2019 Tugas 5 - Inventory
2/11
Investment Cost 340,000
FV Net Asset (340.000/0,85) 400,000
BV Net Asset 350,000
Excess Value 50,000
Alokasi
Land 35,000
Building (10,000)
Patent 25,000
50,000
JURNAL ELIMINASI
Capital Stock 200,000
Beginning R/E 150,000
Land 35,000
Patent 25,000
Building 10,000
Investment in SANTI 340,000
NCI Equity 60,000
Dividend Income 51,000
Dividend 51,000
Dividend Payable 51,000
Dividend Receivable 51,000
Building 1,000
Deprecation expense 1,000
Other operating expense 5,000
Patent 5,000
NCI Expense 17,400
NCI Equity 8,400
Dividend 9,000
* 15% (120.000+1000-5000)
Total COGS 390,000
From other 40,000
350,000
End Inventory 50,000
Purchase from PUAN 400,000
Sales 400,000
COGS 400,000
COGS 10,000
Inventory 10,000
Account Payable 40,000
Account Receivable 40,000
-
8/12/2019 Tugas 5 - Inventory
3/11
Cost Method-INV PT PASTI & Subsidiary
Consolidated Financial Statement
per December 31, 2010
debit credit
Income Statement
Sales 900,000 500,000 400,000 1,000,000
Dividend Income 54,000 54,000 -
COGS (540,000) (300,000) 40,000 400,000 (480,000)
Deprecation expense (30,000) (30,000) (60,000)
Operating expense (102,000) (60,000) (162,000)
Other operating expense (12,000) (10,000) 8,000 (30,000)
Net Income 270,000 100,000 268,000
NCI Expense 9,200 (9,200)
Consolidated Net Income 270,000 100,000 258,800
Beginning R/E 300,000 200,000 200,000 300,000
Dividend (100,000) (60,000) 60,000 (100,000)
Ending R/E 470,000 240,000 458,800
Balance Sheet
Cash 62,000 35,000 97,000
Account Receivable 82,000 45,000 60,000 67,000
Inventory 124,000 100,000 40,000 184,000
Supplies 26,000 20,000 46,000
Land 300,000 300,000 600,000
Building 400,000 200,000 600,000
Equipment 330,000 200,000 530,000
Investment in SUSAH 576,000 576,000 -
Patent 40,000 8,000 32,000
-
Total Assets 1,900,000 900,000 2,156,000
Account Payable 70,000 60,000 60,000 70,000
Other Liabilities 300,000 200,000 500,000
Common Stock 800,000 300,000 300,000 800,000
Paid in Capital 260,000 100,000 100,000 260,000
Retained Earnings 470,000 240,000 458,800
NCI Equity 64,000 67,200
3,200
Total Liabilities + OE 1,900,000 900,000 1,211,200 1,211,200 2,156,000
Consolidated
Financial StatementAccounts PT PASTI PT SUSAH
adjustment & elimination
-
8/12/2019 Tugas 5 - Inventory
4/11
Investment Cost 576,000
FV Net Asset 640,000
BV Net Asset 600,000
Excess Value 40,000
Alokasi
Patent 40,000
40,000
JURNAL ELIMINASI
Common Stock 300,000
Paid in Capital 100,000
Beginning R/E 200,000
Patent 40,000
Investment in SUSAH 576,000
NCI Equity 64,000
Dividend Income 54,000
Dividend 54,000
Other operating expense 8,000
Patent 8,000
NCI Expense 9,200
NCI Equity 3,200
Dividend 6,000
* 10% (100.000-8000)
Total COGS 300,000
End Inventory 100,000
Purchase from Pasti 400,000
Sales 400,000
COGS 400,000
COGS 40,000
Inventory 40,000
Account Payable 60,000
Account Receivable 60,000
-
8/12/2019 Tugas 5 - Inventory
5/11
Cost Method-INV PT PASTI & Subsidiary
Consolidated Financial Statement
per December 31, 2011
debit credit
Income Statement
Sales 1,000,000 600,000 380,000 1,220,000
Dividend Income 72,000 72,000 -
COGS (600,000) (360,000) 48,000 420,000 (588,000)
Deprecation expense (30,000) (30,000) (60,000)
Operating expense (102,000) (80,000) (182,000)
Other operating expense (12,000) (15,000) 8,000 (35,000)
Net Income 328,000 115,000 355,000
NCI Expense 10,700 (10,700)
Consolidated Net Income 328,000 115,000 344,300
Beginning R/E 470,000 240,000 280,000 28,800 458,800
Dividend (120,000) (80,000) 80,000 (120,000)
Ending R/E 678,000 275,000 683,100
Balance Sheet
Cash 72,000 50,000 122,000
Account Receivable 92,000 50,000 60,000 82,000
Inventory 104,000 120,000 48,000 176,000
Supplies 26,000 35,000 61,000
Land 470,000 300,000 770,000
Building 400,000 200,000 600,000
Equipment 330,000 200,000 530,000
Investment in SUSAH 576,000 28,800 604,800 -
Patent 32,000 8,000 24,000
-
Total Assets 2,070,000 955,000 2,365,000
Account Payable 82,000 60,000 60,000 82,000
Other Liabilities 250,000 220,000 470,000
Common Stock 800,000 300,000 300,000 800,000
Paid in Capital 260,000 100,000 100,000 260,000
Retained Earnings 678,000 275,000 683,100
NCI Equity 67,200 69,900
2,700
Total Liabilities + OE 2,070,000 955,000 1,319,500 1,319,500 2,365,000
Consolidated
Financial StatementAccounts PT PASTI PT SUSAH
adjustment & elimination
-
8/12/2019 Tugas 5 - Inventory
6/11
JURNAL PENYESUAIAN
Kenaikan RE
Investment in SUSAH 36,000
Beginning R/E 36,000
Amortisasi
Beginning R/E 7,200
Investment in SUSAH 7,200
JURNAL ELIMINASI
Common Stock 300,000
Paid in Capital 100,000
Beginning R/E 240,000
Patent 32,000
Investment in SUSAH 604,800
NCI Equity 67,200
Dividend Income 72,000
Dividend 72,000
Other operating expense 8,000
Patent 8,000
NCI Expense 10,700
NCI Equity 2,700
Dividend 8,000
* 10% (115.000-8000)
End Inventory 120,000
Total COGS 360,000
Beginning Inventory (100,000)
Purchase from Pasti 380,000
Sales 380,000
COGS 380,000
COGS 48,000
Inventory 48,000
Account Payable 60,000
Account Receivable 60,000
Eliminasi Unrealized Profit
Beginning R/E 40,000
COGS 40,000
-
8/12/2019 Tugas 5 - Inventory
7/11
Cost Method-INV-upstream PT PAPAN & Subsidiary
Consolidated Financial Statement
per December 31, 2010
debit credit
Income Statement
Sales 246,000,000 200,000,000 200,000,000 246,000,000
Dividend Income 18,000,000 18,000,000 -
Cost of Sales (164,000,000) (120,000,000) 14,400,000 200,000,000 (98,400,000)
Deprecation expense (18,200,000) (9,000,000) 2,000,000 (25,200,000)
Interest expense (5,900,000) (3,000,000) (8,900,000)
Other operating expense (15,900,000) (18,000,000) 14,000,000 (47,900,000)
Net Income 60,000,000 50,000,000 65,600,000
NCI Expense 2,360,000 (2,360,000)
Consolidated Net Income 60,000,000 50,000,000 63,240,000
Beginning R/E 249,500,000 49,500,000 49,500,000 249,500,000
Dividend (80,000,000) (20,000,000) 20,000,000 (80,000,000)
Ending R/E 229,500,000 79,500,000 232,740,000
Balance Sheet
Cash 27,650,000 8,700,000 36,350,000
Account Receivable 25,000,000 15,000,000 15,000,000 25,000,000
Inventory 36,000,000 48,000,000 14,400,000 69,600,000
Other Current Assets 46,700,000 9,000,000 55,700,000
Land 216,800,000 97,300,000 314,100,000
Building 214,000,000 274,000,000 20,000,000 468,000,000
Acc. Depreciation-Building (102,500,000) (7,400,000) 2,000,000 (107,900,000)
Equipment 134,400,000 35,900,000 170,300,000
Acc. Depreciation-Equipment (25,000,000) (13,000,000) (38,000,000)
Investment in SANI 404,550,000 404,550,000 -
Patent 70,000,000 14,000,000 56,000,000
Total Assets 977,600,000 467,500,000 1,049,150,000
Account Payable 15,000,000 19,100,000 15,000,000 19,100,000
Other Liabilities 23,500,000 18,900,000 42,400,000
8% Bonds Payable 309,600,000 309,600,000
Capital Stock 400,000,000 350,000,000 350,000,000 400,000,000
Retained Earnings 229,500,000 79,500,000 232,740,000
NCI Equity 44,950,000 45,310,000
360,000
Total Liabilities + OE 977,600,000 467,500,000 735,260,000 735,260,000 1,049,150,000
Consolidated
Financial StatementAccounts PT PAPAN PT SANI
adjustment & elimination
-
8/12/2019 Tugas 5 - Inventory
8/11
Investment Cost 404,550,000
FV Net Asset 449,500,000
BV Net Asset 399,500,000
Excess Value 50,000,000
Alokasi
Building (20,000,000)
Patent 70,000,000
50,000,000
JURNAL ELIMINASI
Capital Stock 350,000,000
Beginning R/E 49,500,000
Patent 70,000,000
Building 20,000,000
Investment in SANI 404,550,000
NCI Equity 44,950,000
Dividend Income 18,000,000
Dividend 18,000,000
Acc. Depreciation-Building 2,000,000
Deprecation expense 2,000,000
Other operating expense 14,000,000
Patent 14,000,000
NCI Expense 2,360,000
NCI Equity 360,000
Dividend 2,000,000
* 10% (50.000.000-14.000.000+2.000.000-14.400.000)
Total COGS 164,000,000
End Inventory 36,000,000
Purchase from SANI 200,000,000
Sales 200,000,000
Cost of Sales 200,000,000
Cost of Sales 14,400,000
Inventory 14,400,000
Account Payable 15,000,000
Account Receivable 15,000,000
-
8/12/2019 Tugas 5 - Inventory
9/11
Cost Method-INV-upstream PT PAPAN & Subsidiary
Consolidated Financial Statement
per December 31, 2011
debit credit
Income Statement
Sales 436,500,000 300,000,000 300,000,000 436,500,000
Dividend Income 36,000,000 36,000,000 -
Cost of Sales (291,000,000) (180,000,000) 18,000,000 314,400,000 (174,600,000)
Deprecation expense (18,200,000) (9,000,000) 2,000,000 (25,200,000)
Interest expense (5,900,000) (3,000,000) (8,900,000)
Other operating expense (15,900,000) (28,000,000) 14,000,000 (57,900,000)
Net Income 141,500,000 80,000,000 169,900,000
NCI Expense 6,440,000 (6,440,000)
Consolidated Net Income 141,500,000 80,000,000 163,460,000
Beginning R/E 229,500,000 79,500,000 92,460,000 16,200,000 232,740,000
Dividend (100,000,000) (40,000,000) 40,000,000 (100,000,000)
Ending R/E 271,000,000 119,500,000 296,200,000
Balance Sheet
Cash 57,650,000 18,700,000 76,350,000
Account Receivable 45,000,000 24,000,000 24,000,000 45,000,000
Inventory 45,000,000 68,000,000 18,000,000 95,000,000
Other Current Assets 46,700,000 13,300,000 60,000,000
Land 350,000,000 97,300,000 447,300,000
Building 214,000,000 274,000,000 20,000,000 468,000,000
Acc. Depreciation-Building (122,500,000) (8,700,000) 4,000,000 (127,200,000)
Equipment 263,200,000 35,900,000 299,100,000
Acc. Depreciation-Equipment (275,500,000) (15,000,000) (290,500,000)
Investment in SANI 404,550,000 16,200,000 420,750,000 -
Patent 56,000,000 14,000,000 42,000,000
Total Assets 1,028,100,000 507,500,000 1,115,050,000
Account Payable 24,000,000 19,100,000 24,000,000 19,100,000
Other Liabilities 23,500,000 18,900,000 42,400,000
8% Bonds Payable 309,600,000 309,600,000
Capital Stock 400,000,000 350,000,000 350,000,000 400,000,000
Retained Earnings 271,000,000 119,500,000 296,200,000
NCI Equity 1,440,000 46,750,000 47,750,000
2,440,000
Total Liabilities + OE 1,028,100,000 507,500,000 918,540,000 918,540,000 1,115,050,000
Consolidated
Financial StatementAccounts PT PAPAN PT SANI
adjustment & elimination
-
8/12/2019 Tugas 5 - Inventory
10/11
JURNAL PENYESUAIAN
Kenaikan RE
Investment in SANI 27,000,000
Beginning R/E 27,000,000
Amortisasi
Beginning R/E 10,800,000
Investment in SANI 10,800,000
JURNAL ELIMINASI
Capital Stock 350,000,000
Beginning R/E 79,500,000
Patent 56,000,000
Acc. Depreciation-Building 2,000,000
Building 20,000,000
Investment in SANI 420,750,000
NCI Equity 46,750,000
Dividend Income 36,000,000
Dividend 36,000,000
Acc. Depreciation-Building 2,000,000
Deprecation expense 2,000,000
Other operating expense 14,000,000
Patent 14,000,000
NCI Expense 6,440,000
NCI Equity 2,440,000
Dividend 4,000,000
* 10% (80.000.000-14.000.000+2.000.000+14.400.000-18.000.000)
Total COGS 291,000,000
End Inventory 45,000,000
Beginning Inventory (36,000,000)
Purchase from SANI 300,000,000
Sales 300,000,000
Cost of Sales 300,000,000
Cost of Sales 18,000,000
Inventory 18,000,000
Account Payable 24,000,000
Account Receivable 24,000,000
Eliminasi Unrealized Profit tahun sebelumnya
Beginning R/E 12,960,000
NCI Equity 1,440,000
Cost of Sales 14,400,000
-
8/12/2019 Tugas 5 - Inventory
11/11
